Compare Bandhan Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.41
1.93
NAV
₹9.53
₹430.58
Fund Started
10 Nov 2025
04 Jun 1999
Fund Size
₹273.07 Cr
₹4063.64 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
-
4.19%
3 Year
-
24.41%
5 Year
-
15.77%
Equity
97.46%
98.16%
Cash
2.52%
1.77%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.65% |
Apollo Hospitals Enterprise Ltd. | 8.97% |
Divi's Laboratories Ltd. | 7.40% |
Max Healthcare Institute Ltd. | 7.14% |
Dr. Reddy's Laboratories Ltd. | 7.12% |
Cipla Ltd. | 6.72% |
JB Chemicals & Pharmaceuticals Ltd. | 4.91% |
Lupin Ltd. | 3.81% |
Mankind Pharma Ltd. | 3.31% |
Ajanta Pharma Ltd. | 3.08% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Divi's Laboratories Ltd. | 6.59% |
Acutaas Chemicals Ltd. | 5.67% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Max Healthcare Institute Ltd. | 4.97% |
Lupin Ltd. | 4.10% |
Aster DM Healthcare Ltd. | 3.96% |
Torrent Pharmaceuticals Ltd. | 3.74% |
Aether Industries Ltd. | 3.56% |
Biocon Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 Nov 2025
04 Jun 1999
